Beckman Coulter Diagnostics has appointed Catherine Jennings, former president of vascular therapies at Boston Scientific, as president. Jennings will lead global strategy and operations for the Danaher-owned clinical diagnostics company.
Lucid Diagnostics reports new Medicare, CPT, and ICD-10 panel recommendations supporting reimbursement and coding for its EsoGuard and EsoCheck esophageal cancer tests, advancing billing and clinical tracking pathways.
Quest Diagnostics will integrate a 50-biomarker lab test panel into the Apple Health app, allowing US users to order preventive testing and access clinical results on iPhone and iPad.
A federal court ordered Guardant Health to pay more than $245 million to TwinStrand Biosciences and the University of Washington in a patent infringement case. Guardant Health is appealing the judgment.
Read More
Seed Healthcare has led a strategic investment in Diadem to support US commercialization of AlzoSure Predict, a blood-based Alzheimer’s diagnostic recently validated in over 900 patients and designated a Breakthrough Device by the FDA.
Read More
Quest Diagnostics will launch an FDA-cleared Roche pTau217 Alzheimer’s blood test and a new multi-biomarker LDT, expanding its AD-Detect portfolio for improved diagnostic accuracy in late 2026.
Read More
Labcorp will offer the FDA-cleared Elecsys pTau-217 blood test, developed by Roche Diagnostics, to aid in identifying amyloid pathology linked to Alzheimer’s in patients 55 and older with cognitive decline.
Read More
Craif Inc has raised $34 million in Series D funding to support a US launch of its urine-based cancer test, expand San Diego lab operations, and advance a pancreatic cancer study and regulatory filing in Japan.
Read More
The strategic alliance will leverage de-identified laboratory data to support quality improvement across 1,526 community health centers and includes a leadership exchange program for chief medical officers.
Read More
Century Health and GI Partners of Illinois have partnered to create a real-world data ecosystem for IBD and MASH, leveraging AI to extract clinical insights from lab data, pathology reports, and imaging to support research and pharmaceutical innovation.
Read More
Cerenome’s CNSide Diagnostics has selected XiFin to provide automated revenue cycle management for its cerebrospinal fluid assay platform, aiming to support increased test volumes and streamline billing as payer coverage expands.
Read More
Epredia will incorporate Leeds NHS Trust’s TANGO quality control technology into pathology slides, aiming to enhance staining consistency for digital pathology and AI diagnostics. Integration is set to begin in late 2026.
Read More
BRAINBox Solutions has secured financing from Pivotal Capital Partners and New Horizon Bank to advance its point-of-care and lab-based concussion diagnostic devices for traumatic brain injury.
Read More
VolitionRx reports progress in licensing talks with over 12 diagnostic firms and advances in clinical and veterinary assays, including a reimbursement submission for its Nu.Q Lung Cancer test and a feline lymphoma study milestone.
Read More
VolitionRx reports its finger-prick lateral flow prototype for sepsis shows strong correlation with its automated Nu.Q NETs assay, supporting point-of-care nucleosome testing for critically ill patients.
Read More
Astorg has completed its acquisition of Thermo Fisher’s global microbiology business, establishing an independent diagnostics company. Dirk Bontridder has been named CEO.
Read More
QIAGEN has received FDA clearance for its QIAstat-Dx BCID GPF Plus AMR Panel, enabling detection of 20 pathogens and 10 antimicrobial resistance markers from positive blood cultures in about one hour.
Read More
bioMérieux hosted a panel on diagnostic delays and received seven 2026 IMV ServiceTrak awards for system performance and customer support at the ADLM Annual Conference & Clinical Lab Expo.
Read More